HepaStem Long-Term Safety Registry - Registry for Patients Who Have Been Administered HepaStem

Trial Profile

HepaStem Long-Term Safety Registry - Registry for Patients Who Have Been Administered HepaStem

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Dec 2017

At a glance

  • Drugs Mesenchymal stem cell therapy (Primary)
  • Indications Crigler-Najjar syndrome; Inborn urea cycle disorders
  • Focus Adverse reactions
  • Acronyms PROLONGSTEM
  • Sponsors Promethera Biosciences
  • Most Recent Events

    • 22 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top